Skip to content

Clinical trials

Observational Carcinoma, Hepatocellular trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Observational Country / region: Austria Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20171
20181
20192
20212
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Hoffmann-La Roche2
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Cardiovascular and Interventional Radiological Society of Europe1
Eisai Inc.1
Maastricht University Medical Center1
Medical University Innsbruck1
Medical University of Graz1
Medical University of Vienna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular11
Lung Neoplasms2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1
Colonic Neoplasms1
End Stage Liver Disease1
Esophageal Neoplasms1
Fatty Liver1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.